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Retinal abnormalities in neurodegenerative diseases Stem cell–based therapies 
Conclusions 
 Neurodegenerative diseases are considered as incurable 
 
 The eye and the neurons of the retina of these patients represent a potential location for new therapies and 
early diagnosis 
 
 OCT appears to be the main potential technique for this early diagnosis and disease study purpose 
 
 Stem cell-based therapies and cell reprogramming techniques offer the potential to generate human retina cells, 
to develop specific human-cell-based retina disease models and to open up new therapeutic strategies for the 
major neurodegenerative disorders  
 
 Describing retinal abnormalities in the main neurodegenerative diseases 
 
 Presenting OCT as the major approach available for non-invasive retinal imaging methods and its 
potential application for early diagnosis, treatment monitoring and study of neurodegenerative 
diseases 
 
 Speculating about the potential use of stem cells as a tool for future effective therapies 
 
 Neurodegenerative diseases are defined as hereditary and sporadic conditions which are characterized by progressive 
dysfunction, degeneration and death of neural cells. They lead to irreversible functional loss and represent a major concern 
in our current society due to their high and increasing incidence. Some of the main neurodegenerative disorders, such as 
Alzheimer, Parkinson and Multiple sclerosis, present visual disturbances and structural changes within the retina. 
 
 Eye as a window to the brain [1]: changes in the retina of patients can help to predict changes in the brain, since the retina 
is a direct extension of the CNS. This early diagnosis can help solving the current lack of reliable non-invasive diagnostic 
techniques, limiting the application of an effective treatment. 
 
 Stem cell research offers the possibility of developing new therapeutic approaches to prevent and restore neuronal cell 
loss at the retina. 
 
Data displayed in this poster has been obtained from scientific literature research of recent papers 
and reviews using the searching engine Pubmed-NCBI and the scientific journals Nature and 
Science. Selection of papers mainly based on date of publication and quality of journal. 
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 Primary neurodegenerative disorder and most common form of dementia. Most common symptoms are memory 
impairment, language deficits and a gradual loss of bodily function. 
 
 Etiology on debate. Two major lesions: extracellular beta-amyloid (A-β) neuritic plaques and p-tau intracellular 
neurofibrillary tangles. 
 
 Difficulty with reading, finding objects and recognizing colors, abnormalities in depth and motor perception and reduced 
spatial contrast sensitivity  RNFL and macular thinning, vacuolar degeneration and reduced numbers of RGCs, an 
increase in the optic disc cupping, reduced retinal blood flow, a pathological accumulation of A-β and p-tau, hypertrophy and 
proliferation of astrocytes and an amyloid precursor protein (APP) immunoreactivity [2] 
 
 OCT to determine RNFL and macular thickness, Detection of apoptosing retinal cells (DARC) for assessing treatment 
efficacy and evaluation of ocular vascular function in correlation with cognitive decline. 
 Second most common neurodegenerative disorder. Main motor symptoms are tremor, bradykinesia rigidity and postural 
instability, also non-motor symptoms 
.  
 Largey idiopathic. It shows a progressive depletion of the neurotransmitter dopamine in the pars compacta of the 
substantia nigra. Major alteration: Lewy bodies  
 
Visual acuity is diminished, visual hallucinations, `motion blur´ in contrast perception, disturbed color vision, inappropriately 
`dark-adapted´ state  swelling of photoreceptors and RGCs, pale intracellular inclusions in the outer plexiform layer, 
morphological deterioration of the perifoveal dopaminergic plexus and RNFL and macular thinning [3,4] 
 
OCT to determine RNFL thinning and correlate it with disease severity 
 
 Chronic immune-mediated disease of the CNS which affects the myelin 
sheath of the nerves at the brain and the spinal cord, showing heterogeneous 
decline in motor and cognitive functions. Two phenotypes: relapsing remitting 
MS (RR MS) and secondary progressive (SP) MS. 
 
Demyelinating lesions in the white (WM) and grey matter (GM) of the CNS are 
the classical hallmark of the disease. 
 
Decrease in visual acuity and contrast sensitivity, defects in binocular and 
color vision, diplopia and blurred vision, photophobia, excessive glare, 
photopsias, oscillopsia, abnormal eye movements  retinal atrophy and 
inflammation, RNFL and macular thickness, loss of RGCs, amacrine and bipolar 
cells, astrocyte hypertrophy and proliferation, abnormalities in the iris in chronic 
cases, pathological cupping of the optic disc, retinal periphlebitis and in 20% of 
the cases optic neuritis [5] 
 
OCT shows RNFL, macular, RGCs layer and inner plexiform layer thickness, 
which can be correlated with the level of brain atrophy and nerve damage. Low-
contrast letter acuity (LCLA) and alteration of the visual evoked potential (VEP) 
latencies also useful for early diagnosis 
 
Stem cells are unspecialized and capable of 
giving rise to any type of cell by renewing 
themselves through cell division in response to 
external (microenvironment) and internal (genes) 




Neural stem cells (NSCs) are a potential therapeutic tool for neurodegenerative diseases. In the adult 
brain they´re mainly restricted in to two tissue niches: the subventricular zone (SVZ) and the 
subgranular zone (SGZ). They can give rise to neurons (neurogenesis) and astrocytes and 








genetically-modified NSCs overexpressing choline acetyltransferase (ChAT) 
and the A-β degrading enzyme neprilysin19 (sNEP) enhance regeneration, 
memory restoration and target AD pathology 
transplantation of human brain-derived NSCs and NSCs derived from 
human ESCs establish synaptic connections with host cells and release 
dopamine 
Oligodendrocyte progenitor cells (OPCs) and NSCs transplantation 
promote endogenous remyelination and neuronal regeneration, blocking 
also the uncontrolled inflammation 
Potential applications of stem cells 
Cell replacement 
approaches 
Disease modeling Neuroprotection Neuroregeneration 
Cell reprogramming enables the generation of any somatic cell type by genetic manipulation in a cell 
culture dish [7] 
 Induced pluripotent stem cells (iPSCs): derived from patient somatic cells using  four  
transcription factors 
 
Induced retinal progenitor cells (iRPCs) and induced retinal neurons (iRN): only one 
reprogramming step, transcriptional factors: Brn2, Ascl1, Myt1l, NeuroD1 (human models) 
 
Adult stem cells physiologically generate the cell types of the tissue in which they reside at the 
body 
 
Oct4, Sox2, Klf4, c-Myc and Fbx15 
Figure 2 Classification of stem cells. Adapted from Human 
Anatomy and Physiology, an OpenStax College resource 
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